Seeking Alpha

Collins Stewart is reiterating a Buy and $475 PT on Intuitive Surgical (ISRG) following the...

Collins Stewart is reiterating a Buy and $475 PT on Intuitive Surgical (ISRG) following the FDA's recent approval of a vessel sealer product for its EndoWrist instrument line. The firm expects the product to boost the average revenue Intuitive generates from procedures featuring its Da Vinci surgical robots.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)